Progress in immune-modulating biomaterials for complement system regulation
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Complement system in diseases · Nanoplatforms for cancer theranostics · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Complement, a target for therapy in inflammatory and degenerative diseases10.1038/nrd4657 ↗
2. First of two parts
3. The complement system and diabetic retinopathy
4. The role of complement in kidney disease10.1038/s41581-023-00766-1 ↗
5. The complement system and human autoimmune diseases10.1016/j.jaut.2022.102979 ↗
6. Function and dysfunction of complement factor H during formation of lipid-rich deposits10.3389/fimmu.2020.611830 ↗
7. Clinical promise of next-generation complement therapeutics10.1038/s41573-019-0031-6 ↗
8. Intelligent vascularized 3D/4D/5D/6D-printed tissue scaffolds
9. Liposome composition in drug delivery design, synthesis, characterization, and clinical application10.1016/j.addr.2021.113851 ↗
10. Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections10.1038/s41579-020-0420-1 ↗
11. Complement-regulatory biomaterial coatings: activity and selectivity profile of the factor H-binding peptide 5C610.1016/j.actbio.2022.10.055 ↗
12. The interplay between PEGylated nanoparticles and blood immune system10.1016/j.addr.2023.115044 ↗
13. Interplay between biomaterials and the immune system: challenges and opportunities in regenerative medicine10.1016/j.actbio.2022.11.003 ↗
14. Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition?10.1016/j.it.2009.09.005 ↗
15. Nanoparticle physicochemical properties determine the activation of intracellular complement10.1016/j.nano.2019.02.002 ↗
16. Tipping the balance: intricate roles of the complement system in disease and therapy10.1007/s00281-021-00892-7 ↗
17. Complement activation contributes to subretinal fibrosis through the induction of epithelial-to-mesenchymal transition (EMT) in retinal pigment epithelial cells10.1186/s12974-022-02546-3 ↗
18. The mechanism and modulation of complement activation on polymer grafted cells10.1016/j.actbio.2015.11.022 ↗
19. Engineering immunomodulatory biomaterials for type 1 diabetes10.1038/s41578-019-0112-5 ↗
20. Exosome loaded immunomodulatory biomaterials alleviate local immune response in immunocompetent diabetic mice post islet xenotransplantation10.1038/s42003-021-02229-4 ↗
21. Design of therapeutic biomaterials to control inflammation10.1038/s41578-022-00426-z ↗
22. Targeted modulation of immune cells and tissues using engineered biomaterials10.1038/s44222-022-00016-2 ↗
23. Engineering patient-specific cancer immunotherapies10.1038/s41551-019-0436-x ↗
24. Precision drug delivery to the central nervous system using engineered nanoparticles10.1038/s41578-024-00695-w ↗
25. Design of microbial catalysts for two-stage processes10.1038/s44222-024-00225-x ↗
26. A guide to complement biology, pathology and therapeutic opportunity10.1038/s41577-023-00926-1 ↗
27. Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses10.1038/nm933 ↗
28. Antiphospholipid syndrome: complement activation, complement gene mutations, and therapeutic implications10.1111/jth.15082 ↗
29. Complement component C3: a structural perspective and potential therapeutic implications10.1016/j.smim.2022.101627 ↗
30. The classical pathway triggers pathogenic complement activation in membranous nephropathy10.1038/s41467-023-36068-0 ↗
31. Recent applications of immunomodulatory biomaterials for disease immunotherapy
32. Local opsonization for apoptosis?10.1038/ni0602-510 ↗
33. F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins10.1038/nm836 ↗
34. Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection10.1038/nm0402-373 ↗
35. Regulation of B cell functions by Toll-like receptors and complement10.1016/j.imlet.2016.07.015 ↗
36. Complement and the regulation of T cell responses10.1146/annurev-immunol-042617-053245 ↗
37. Complement in human disease: approved and up-and-coming therapeutics10.1016/S0140-6736(23)01524-6 ↗
38. Immunomodulatory biomaterials for tissue repair10.1021/acs.chemrev.0c00895 ↗
39. Engineering immunomodulatory biomaterials for regenerating the infarcted myocardium10.3389/fbioe.2020.00292 ↗
40. Design principles for immunomodulatory biomaterials10.1021/acsabm.4c00537 ↗
41. Matrix stiffness regulates macrophage polarisation via the Piezo1-YAP signalling axis10.1111/cpr.13640 ↗
42. Granzyme K activates the entire complement cascade10.1038/s41586-025-08713-9 ↗
43. Complement system activation: bridging physiology, pathophysiology, and therapy10.1007/s00134-024-07611-4 ↗
44. PEGylation technology: addressing concerns, moving forward10.1080/10717544.2025.2494775 ↗
45. Complement and the central nervous system: emerging roles in development, protection and regeneration10.1038/icb.2010.48 ↗
46. Activation of the complement system in an osteosarcoma cell line promotes angiogenesis through enhanced production of growth factors10.1038/s41598-018-23851-z ↗
47. Uncovering supramolecular chirality codes for the design of tunable biomaterials10.1038/s41467-024-45019-2 ↗
48. Biomaterials to enhance adoptive cell therapy10.1038/s44222-023-00148-z ↗
49. Biomaterials functionalization using a novel peptide that selectively binds to a conducting polymer10.1038/nmat1397 ↗
50. Complement genetics, deficiencies, and disease associations10.1007/s13238-012-2924-6 ↗
51. Complement-here, there and everywhere, but what about the transplanted organ?10.1016/j.smim.2016.04.007 ↗
52. Constitutive expression and regulation of rat complement factor H in primary cultures of hepatocytes, Kupffer cells, and two hepatoma cell lines10.1038/labinvest.3780410 ↗
53. Expression and regulation of complement factors H and I in rat and human cells: some critical notes10.1016/S0161-5890(01)00045-1 ↗
54. Expression of the human complement C8 subunits is independently regulated by interleukin 1 beta, interleukin 6, and interferon gamma10.1016/S0162-3109(97)00077-5 ↗
55. The role of complement in liver injury, regeneration, and transplantation10.1002/hep.30508 ↗
56. The proinflammatory mediators C3a and C5a are essential for liver regeneration10.1084/jem.20030374 ↗
57. IL-6 pathway in the liver: from physiopathology to therapy10.1016/j.jhep.2016.02.004 ↗
58. Systems analysis of the complement-induced priming phase of liver regeneration10.4049/jimmunol.1600628 ↗
59. Interaction of the factor H family proteins FHR-1 and FHR-5 with DNA and dead cells: implications for the regulation of complement activation and opsonization10.3389/fimmu.2020.01297 ↗
60. The role of complement in angiogenesis
61. C5a promotes migration, proliferation, and vessel formation in endothelial cells10.1007/s00011-010-0178-4 ↗
62. Complement factor H in molecular regulation of angiogenesis
63. Podocytes produce and secrete functional complement C3 and complement factor H
64. Production of complement components by cells of the immune system10.1111/cei.12952 ↗
65. Biosynthesis and secretion of complement component (C3) by activated human polymorphonuclear leukocytes10.4049/jimmunol.149.4.1348 ↗
66. Human polymorphonuclear leukocytes store large amounts of terminal complement components C7 and C6, which may be released on stimulation10.4049/jimmunol.154.9.4734 ↗
67. Justiz Vaillant AA, Vashisht R, Zito PM. Immediate Hypersensitivity Reactions (Archived). StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2025, StatPearls Publishing LLC.; 2025.
68. Human skin mast cells express complement factors C3 and C510.4049/jimmunol.1202889 ↗
69. Maturation of dendritic cells abrogates C1q production in vivo and in vitro10.1182/blood-2003-09-3046 ↗
70. Human monocyte-derived dendritic cells are a source of several complement proteins10.1007/s00011-006-0068-y ↗
71. Expression and regulation of complement receptors by human natural killer cells10.1016/j.imbio.2014.03.018 ↗
72. CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions10.1111/j.1365-2249.1993.tb03377.x ↗
73. Synthesis of complement component C5 by human B and T lymphoblastoid cell lines10.1007/BF00211549 ↗
74. Complement factors H and I synthesized by B cell lines function to generate a growth factor activity from C310.4049/jimmunol.150.9.4052 ↗
75. Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection10.4049/jimmunol.181.7.4580 ↗
76. Complosome - the intracellular complement system10.1038/s41581-023-00704-1 ↗
77. Osteogenic potential of a polyethylene glycol hydrogel functionalized with poly-lysine dendrigrafts (DGL) for bone regeneration10.3390/ma16020862 ↗
78. Gene expression in liver injury caused by long-term exposure to titanium dioxide nanoparticles in mice10.1093/toxsci/kfs153 ↗
79. Factor D10.1111/imr.13155 ↗
80. Novel insights and recent progress in osteoimmunology10.1016/j.it.2025.02.003 ↗
81. T cell related osteoimmunology in fracture healing: potential targets for augmenting bone regeneration10.1016/j.jot.2024.12.004 ↗
82. RKIP regulates bone marrow macrophage differentiation to mediate osteoclastogenesis and H-type vessel formation10.1038/s41467-025-62972-8 ↗
83. Osteoimmunology: crosstalk between T cells and osteoclasts in osteoporosis10.1007/s12016-025-09046-1 ↗
84. Osteoimmunology in osteoarthritis: unraveling the interplay of immunity, inflammation, and joint degeneration10.2147/JIR.S514002 ↗
85. Osteoimmunology of fracture healing10.1007/s11914-024-00869-z ↗
86. Osteoimmunology and aging: mechanisms, implications, and therapeutic perspectives10.1016/j.arr.2025.102822 ↗
87. Obesity induces osteoimmunology imbalance: molecular mechanisms and clinical implications10.1016/j.biopha.2024.117139 ↗
88. Role of mesenchymal stem cells in bone regeneration and fracture repair: a review10.1007/s00264-013-2059-2 ↗
89. Enhancing bone grafting outcomes: a comprehensive review of antibacterial artificial composite bone scaffolds10.12659/MSM.939972 ↗
90. History of gene therapy10.1016/j.gene.2013.03.137 ↗
91. Multiple components in serum contribute to hepatic transgene expression by lipoplex in mice10.1002/jgm.1618 ↗
92. Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo10.1038/nnano.2016.269 ↗
93. Protein corona mediated liposomal drug delivery for bacterial infection management
94. Impact of spontaneous liposome modification with phospholipid polymer-lipid conjugates on protein interactions10.1080/14686996.2022.2146466 ↗
95. Zwitterionic brush-grafted interfacial bio-lubricant evades complement C3-mediated macrophage phagocytosis for osteoarthritis therapy10.1002/adma.202501137 ↗
96. Zwitterionic poly(ethylene glycol) nanoparticles minimize protein adsorption and immunogenicity for improved biological fate10.1021/acsami.4c20890 ↗
97. Control of the molecular permeability of polysaccharide composite films utilizing a molecular imprinting approach10.1038/s41428-021-00605-9 ↗
98. Surface treatment of polymeric materials controlling the adhesion of biomolecules10.3390/jfb3030528 ↗
99. Topological structure of electrospun membrane regulates immune response, angiogenesis and bone regeneration10.1016/j.actbio.2021.05.042 ↗
100. Nanoscale topographical effects on the adsorption behavior of bone morphogenetic protein-2 on graphite10.3390/ijms23052432 ↗